Kuznetsov A I, Idel'son L I, Mazurov A V
Biull Eksp Biol Med. 1991 Jun;111(6):641-4.
Direct radioimmune assay (RIA) have been developed for detection of antibodies associated wild platelet membrane. Platelets from 12 patients with idiopathic thrombocytopenic purpura (ITP) and 27 patients with chronic lymphocytic leukemia (CLL) (platelet count (100,000 in 1 microliters) have been tested. Antibodies on platelets surface have been detected in all 12 patients with ITP and in 21 patients with CLL. In 6 CLL patients the number of immunoglobulins associated with platelets surface does not increase control level. It is possible, that in some CLL patients development of thrombocytopenia is mediated not only by platelet associated antibodies but by other mechanisms, one of which can be linked with the depression of megakaryocytes growth in bone marrow. Direct RIA for measurement of antibodies on platelet surface detect antiplatelet antibodies with higher frequency than indirect enzyme-linked-immunosorbent-assay (ELISA), developed earlier for assessment of antiplatelet antibodies in serum. Increase of platelet count in CLL patients after steroid and cytostatic treatment correlated with the decrease of platelet surface associated antibodies.
已开发出直接放射免疫测定法(RIA)用于检测与血小板膜相关的抗体。对12例特发性血小板减少性紫癜(ITP)患者和27例慢性淋巴细胞白血病(CLL)患者(血小板计数为每微升100,000)的血小板进行了检测。在所有12例ITP患者和21例CLL患者中均检测到血小板表面的抗体。在6例CLL患者中,与血小板表面相关的免疫球蛋白数量未增加至对照水平。有可能在某些CLL患者中,血小板减少症的发生不仅由血小板相关抗体介导,还由其他机制介导,其中之一可能与骨髓中巨核细胞生长受抑制有关。用于测量血小板表面抗体的直接RIA检测抗血小板抗体的频率高于早期开发的用于评估血清中抗血小板抗体的间接酶联免疫吸附测定法(ELISA)。CLL患者在接受类固醇和细胞抑制治疗后血小板计数的增加与血小板表面相关抗体的减少相关。